| Target Price | HK$103.69 |
| Price | HK$57.20 |
| Potential |
81.28%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Shanghai Henlius Biotech I-h 2027 .
The average Shanghai Henlius Biotech I-h target price is HK$103.69.
This is
81.28%
register free of charge
HK$112.48
96.64%
register free of charge
HK$96.05
67.92%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Shanghai Henlius Biotech I-h to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Shanghai Henlius Biotech I-h stock has an average upside potential 2027 of
81.28%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 7.79 | 9.00 |
| 16.46% | 15.58% | |
| EBITDA Margin | 19.71% | 19.12% |
| 14.11% | 2.99% | |
| Net Margin | 12.41% | 11.54% |
| 13.45% | 6.98% |
7 Analysts have issued a sales forecast Shanghai Henlius Biotech I-h 2026 . The average Shanghai Henlius Biotech I-h sales estimate is
This results in the following potential growth metrics:
8 Shanghai Henlius Biotech I-h Analysts have issued a net profit forecast 2026. The average Shanghai Henlius Biotech I-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 1.77 | 1.91 |
| 0.57% | 7.91% | |
| P/E | 30.02 | |
| EV/Sales | 3.90 |
8 Analysts have issued a Shanghai Henlius Biotech I-h forecast for earnings per share. The average Shanghai Henlius Biotech I-h EPS is
This results in the following potential growth metrics and future valuations:
Shanghai Henlius Biotech I-h...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


